• Home
  • Study Details
By physician referral or invitation only

A nasal swab study to assess the efficacy of vaccination in the prevention of SARS-CoV-2 infection among individuals enrolled in a Phase 3 efficacy trial of a SARS-CoV-2 recombinant spike protein (rS) vaccine with Matrix-M1™ (M1) adjuvant

This study aims to estimate the efficacy of SARS-CoV-2 rS/M1 vaccine against infection

Age & Gender

  • 12 years ~ 17 years
  • Male, Female, Gender Inclusive

Contact the Team


Thank you for your interest, but this study is recruiting by invitation only.

United States (Nationwide)

Additional Study Information

Principal Investigator

Cindy Gay
Medicine-Infectious Diseases

Study Type

Clinical or Medical

Study Topics

Immune System/Infections

IRB Number


logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.


  • This email address is being protected from spambots. You need JavaScript enabled to view it.